On Wednesday, Ford Motor Company (NYSE: F) took legal action against Blue Cross Blue Shield Association in a U.S. court. The lawsuit accuses the insurer of engaging in a price-fixing conspiracy, which resulted in inflated costs for health insurance products for Ford’s employees. The lawsuit was filed in Detroit federal court. It claims that Blue …
Apple Inc. (NASDAQ: AAPL) has announced plans to expand and revamp its retail chain, aiming to deepen its presence in China and other parts of Asia while transforming established locations in the US and Europe. The tech giant is in discussions to open 15 new stores across the Asia-Pacific region, five locations in Europe and …
Apple Inc. (AAPL) Plans Major Retail Expansion in Asia, Europe, and North America Read More »
Credit Suisse Group AG (NYSE: CS) experienced a significant boost in its stock price, rising by 4.26% to reach $0.86 on Thursday. This surge comes in response to the latest development that the financial services firm has successfully repaid the government-backed liquidity it received, as confirmed by Swiss Finance Minister Karin Keller-Sutter. During an interview …
Credit Suisse Group AG (NYSE: CS) Repays Government-Backed Liquidity, Stock Price Surges Read More »
NIO Inc. (NYSE: NIO) has announced its May 2023 delivery results. The company successfully delivered a total of 6,155 vehicles during this month. Among these deliveries, there were 2,396 premium smart electric SUVs and 3,759 premium smart electric sedans. These numbers have contributed to NIO’s cumulative deliveries reaching an impressive 333,410 vehicles as of May …
NIO Inc. (NIO) to Introduce ET5 Touring: A Mid-Size Smart Electric Tourer in June 2023 Read More »
Palantir Technologies Inc. (NYSE: PLTR), a leading AI company, is making groundbreaking advancements in artificial intelligence. These remarkable innovations have left its Chief Executive Officer, Alex Karp, questioning whether they should sell their technology to certain clients. The company’s stock has been soaring for weeks due to unprecedented demand for its AI products. This remarkable …
Palantir CEO Raises Concerns Over Selling Powerful AI Technology to Certain Clients Read More »
Shares of Tesla, Inc. (NASDAQ: TSLA) rose by 1.94% in Thursday’s afternoon trade. The boost comes as the city’s Communist Party Secretary Chen Jining extended a warm welcome to the company, urging them to introduce more new products and technology in Shanghai, China. This news has sparked enthusiasm among investors and Tesla enthusiasts worldwide. The …
Tesla, Inc. (NASDAQ: TSLA) Receives Warm Welcome from Chinese Officials, Shares Soar Read More »
Investors have filed a proposed class action lawsuit against Elon Musk, CEO of Tesla, Inc. (NASDAQ: TSLA), accusing him of insider trading and manipulating the cryptocurrency Dogecoin (DOGE). The lawsuit alleges that Musk’s actions have cost investors billions of dollars. The investors filed a complaint in Manhattan federal court on Wednesday night, alleging that Musk …
Elon Musk Faces Class Action Lawsuit Over Dogecoin (DOGE) Manipulation Read More »
Lucid Group, Inc. (NASDAQ: LCID) experienced a significant drop of 16.62% in its shares on Thursday, with prices hitting $6.47. The sharp decline in stock value came after the company made a major announcement regarding its pricing of a public offering of common stock, along with a corresponding investment by an affiliate of PIF, yielding …
Lucid Group, Inc. (LCID) Stock Takes a Hit Amid Public Offering Announcement Read More »
Shares of U Power Limited (NASDAQ: UCAR) skyrocketed 187.78% on Thursday to reach $8.95. This unprecedented increase in stock value is attributed to the company’s recent strategic cooperation agreement with Quantum Solutions Co., Ltd. The partnership aims to drive business initiatives in various sectors, including marketing, research, and development of new energy vehicles, financial technologies, …
Shares of Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) skyrocketed 97.30% on Wednesday to reach $0.37. This remarkable surge comes on the heels of the company’s recent agreement with the U.S. Food and Drug Administration (FDA) regarding a crucial Phase 3 study for their groundbreaking product, AR-301. Aridis Pharmaceuticals, Inc. has been working tirelessly on the development …
